Revelation Biosciences Inc.
13F holders, Q3 2025 (September 30)10holders +9
4new positions
0sold out
$1.42avg. 13F price*
At the end of Q3 2025, 10 institutions reported holding Revelation Biosciences Inc. in their 13F filings, up 9 from Q2 2025. 4 opened new positions and 0 sold out. The largest holders were Sabby Management, LLC ($294K), Armistice Capital, LLC ($114K) and DRW Securities, LLC ($110K).
- Company
- Revelation Biosciences Inc.
- CUSIP
- 76135L705
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $244K |
| Exits | 0 | $0 |
All 13F filers, Q2 2025 → Q3 2025: 313,304 shares bought and 4,625 shares sold, net +308,679 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 10 holders
| Sabby Management, LLC | 1.54% | Add +214.7% | 207,051 | $294K |
| Armistice Capital, LLC | 0.00% | New | 80,000 | $114K |
| DRW Securities, LLC | 0.01% | New | 77,272 | $110K |
| Jane Street Group, LLC | 0.00% | New | 14,764 | $21K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -84.7% | 534 | $758 |
| SBI Securities Co., Ltd. | 0.00% | Reduce -67.0% | 458 | $650 |
| Bank of America Corp. | 0.00% | Add +55.6% | 14 | $20 |
| UBS Group AG | 0.00% | Reduce -99.7% | 2 | $3 |
| Danske Bank A/S | 0.00% | No change | 1 | $1 |
| Citigroup Inc. | 0.00% | New | 1 | $1 |
"% of holder's portfolio" is REVELATION BIOSCIENCES INC's weight in each manager's 13F, not the share of Revelation Biosciences Inc. the manager owns.